Swiss National Bank Trims Elevance Health Holdings

Institutional investor reduces stake in major U.S. health benefits company

Published on Mar. 10, 2026

Got story updates? Submit your updates here. ›

Swiss National Bank, a major institutional investor, has reduced its position in Elevance Health, Inc. (NYSE:ELV) by 5% during the third quarter. The firm previously owned 651,300 shares of the company's stock, valued at $210.45 million, but sold 34,000 shares during the period.

Why it matters

Elevance Health is one of the largest health benefits companies in the United States, providing medical and specialty health plans for individuals, employers, and government programs. Changes in ownership by major institutional investors like Swiss National Bank can signal broader market trends and investor sentiment around the company's performance and outlook.

The details

According to a recent disclosure with the Securities and Exchange Commission, Swiss National Bank cut its position in Elevance Health by 5% during the third quarter. The firm previously owned 651,300 shares of the company's stock, valued at $210.45 million, but sold 34,000 shares during the period. Elevance Health, formerly known as Anthem, Inc., is a leading provider of health insurance products and related services, with a focus on integrated healthcare delivery.

  • Swiss National Bank reduced its Elevance Health holdings in the third quarter of 2026.

The players

Swiss National Bank

A major institutional investor and central banking authority of Switzerland.

Elevance Health, Inc.

A large U.S.-based health benefits company that provides a broad range of health insurance products and related services.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Swiss National Bank's Elevance Health holdings could signal broader market concerns or a shift in investor sentiment around the health benefits company's performance and outlook, though the reasons behind the move are not entirely clear from the available information.